256 related articles for article (PubMed ID: 35399517)
61. Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer.
Huang J; Chen W; Jie Z; Jiang M
Front Oncol; 2022; 12():820568. PubMed ID: 35237521
[TBL] [Abstract][Full Text] [Related]
62. EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer.
Zheng P; Liu X; Li H; Gao L; Yu Y; Wang N; Chen H
Front Genet; 2021; 12():796592. PubMed ID: 35126464
[No Abstract] [Full Text] [Related]
63. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
64. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
65. High
Yuan L; Hu C; Yu P; Bao Z; Xia Y; Zhang B; Wang Y
Ann Transl Med; 2022 Sep; 10(18):990. PubMed ID: 36267769
[TBL] [Abstract][Full Text] [Related]
66. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
67. DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer.
Hu SF; Lin X; Xu LP; Chen HG; Guo JF; Jin L
Technol Cancer Res Treat; 2020; 19():1533033820934133. PubMed ID: 32588770
[TBL] [Abstract][Full Text] [Related]
68. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer.
Yang WJ; Shi L; Wang XM; Yang GW
Aging (Albany NY); 2021 Aug; 13(16):20836-20852. PubMed ID: 34461608
[TBL] [Abstract][Full Text] [Related]
69. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
70. The Pan-Cancer Crosstalk Between the
Xie R; Yuan M; Jiang Y
Front Cell Dev Biol; 2022; 10():790947. PubMed ID: 35309935
[No Abstract] [Full Text] [Related]
71. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.
Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S
Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148
[No Abstract] [Full Text] [Related]
72. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
73. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
[TBL] [Abstract][Full Text] [Related]
74. MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and Experiments.
Zhu H; Wang G; Zhu H; Xu A
J Cancer; 2021; 12(12):3611-3625. PubMed ID: 33995638
[No Abstract] [Full Text] [Related]
75. ANXA9 as a novel prognostic biomarker associated with immune infiltrates in gastric cancer.
Zhang T; Yu S; Zhao S
PeerJ; 2021; 9():e12605. PubMed ID: 35003923
[TBL] [Abstract][Full Text] [Related]
76. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
Fang D; Lu G
Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
[TBL] [Abstract][Full Text] [Related]
77. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
Liu D; Liu S; Fang Y; Liu L; Hu K
Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
[No Abstract] [Full Text] [Related]
78. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
79. Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer.
Wu Y; Zheng J; Yan Y; Liu J; Zhou Y
Int J Gen Med; 2022; 15():927-936. PubMed ID: 35115818
[TBL] [Abstract][Full Text] [Related]
80. Comprehensive Analysis of
Liu D; Sun C; Kim N; Bhan C; Tuason JPW; Chen Y; Ma S; Huang Y; Cheng C; Zhou Q; Zhang K
Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34205081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
